![Institute of Biomedical Research Corporation New (PK)](/common/images/company/NO_MRES.png)
MRES: M2Bio Sciences Appoints Adrian J. Maizey, Accomplished CEO and Financial Expert, to Advisory Board CAPE TOWN, SOUTH AFRICA -- July 19, 2023 -- InvestorsHub NewsWire...
MRES: M2Bio Sciences Unveils an Exciting Line of Purple, White, and Green Teas from Kenya, Offering Extraordinary Health and Medicinal Benefits CAPE TOWN, SOUTH AFRICA -- July 14, 2023...
MRES: M2Bio Sciences Unveils Explainer Video Showcasing Groundbreaking NFTs and Altcoins for Drug Discovery, Revolutionizing Investment Access CAPE TOWN, SOUTH AFRICA...
MRES: Institute of Biomedical Research Announces Application for Name Change and New Ticker Symbol in Anticipation of Future M&A Activities and Senior Listing CAPE...
MRES: M2Bio Sciences Enters into Letter of Intent to Acquire Crypto Exchange JDAX CAPE TOWN, SOUTH AFRICA -- June 26, 2023 -- InvestorsHub NewsWire -- Institute of Biomedical...
MRES: M2Bio Sciences Establishes Research Chair at The University of Pretoria for Phytomedicines CAPE TOWN, SOUTH AFRICA -- June 16, 2023 -- InvestorsHub NewsWire -- Institute of...
MRES: M2Enviro Expands R&D Efforts to Explore Diverse Classes of Mycelium Composite Materials for Commercialization CAPE TOWN, SOUTH AFRICA -- June 14, 2023...
MRES: Institute of Biomedical Research unveils artificial intelligence (AI) powered initiatives within its CBD product range, psilocybin research, and cardiometabolic health solutions CAPE...
CAPE TOWN, SOUTH AFRICA -- April 6, 2023 -- Institute of Biomedical Research (OTC PINK: MRES) ("M2Bio Sciences'' or the "Company"), a bioceutical company focused on...
Neuro-Biotech Corp. & Credo-TM announce New North American Dedicated Telephone Number PR Newswire KAZAN, Russian Federation, April 13 KAZAN, Russian Federation, April 13 /PRNewswire/...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.00285 | 17.2727272727 | 0.0165 | 0.0235 | 0.016 | 1013629 | 0.02051078 | CS |
4 | 0.00395 | 25.6493506494 | 0.0154 | 0.028 | 0.0141 | 1367392 | 0.02205955 | CS |
12 | 0.01515 | 360.714285714 | 0.0042 | 0.028 | 0.0001 | 1108350 | 0.01714381 | CS |
26 | 0.01205 | 165.068493151 | 0.0073 | 0.028 | 0.0001 | 725112 | 0.01419655 | CS |
52 | 0.0106 | 121.142857143 | 0.00875 | 0.028 | 0.0001 | 615537 | 0.01229647 | CS |
156 | 0.00605 | 45.4887218045 | 0.0133 | 0.0367 | 0.0001 | 923713 | 0.01507488 | CS |
260 | 0.018825 | 3585.71428571 | 0.000525 | 0.045 | 0.0001 | 985305 | 0.01435414 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales